Category Archives: Mesenchymal Stem Cells

Stemedix Stem Cell Therapy for ALS - Patient Experience: Dr. Robert K., MD Stemeidx treats Dr. Robert K., MD. for ALS (Amyotrophic Lateral Sclerosis). Dr. Robert speaks about his patient experience with Stemedix after receiving Stemedix adipose stem cell treatment.... By: Stemedix … Continue reading →

Analysis of circulating tumor cells (CTCs) in a mouse model of pancreatic cancer identified distinct patterns of gene expression in several groups of CTCs, including significant differences from the primary tumor that may contribute to the ability to generate metastases. In their study reported in the Sept. 25 issue of Cell Reports, investigators from the Massachusetts General Hospital (MGH) Cancer Center identified several different classes of pancreatic CTCs and found unexpected factors that may prove to be targets for improved treatment of the deadly tumor. "Our ability to combine a novel microfluidic CTC isolation device, developed here at MGH, with single-cell RNA sequencing has given us new biological insights into these cells and revealed novel avenues to try and block the spread of cancer," says lead author David T. Ting, MD, MGH Cancer Center. Pancreatic cancer is among the most deadly of tumors because it spreads rapidly via CTCs carried in the bloodstream. The earliest technologies for isolating CTCs from blood samples relied on interactions with known tumor-specific marker proteins, potentially missing cells that did not express those particular markers. The device used in the current study, called the CTC-iChip, enables the isolation of all CTCs in a blood sample, … Continue reading →

PUBLIC RELEASE DATE: 22-Sep-2014 Contact: Katie Marquedant kmarquedant@partners.org 617-726-0337 Massachusetts General Hospital @MassGeneralNews Analysis of circulating tumor cells (CTCs) in a mouse model of pancreatic cancer identified distinct patterns of gene expression in several groups of CTCs, including significant differences from the primary tumor that may contribute to the ability to generate metastases. In their study reported in the Sept. 25 issue of Cell Reports, investigators from the Massachusetts General Hospital (MGH) Cancer Center identified several different classes of pancreatic CTCs and found unexpected factors that may prove to be targets for improved treatment of the deadly tumor. "Our ability to combine a novel microfluidic CTC isolation device, developed here at MGH, with single-cell RNA sequencing has given us new biological insights into these cells and revealed novel avenues to try and block the spread of cancer," says lead author David T. Ting, MD, MGH Cancer Center. Pancreatic cancer is among the most deadly of tumors because it spreads rapidly via CTCs carried in the bloodstream. The earliest technologies for isolating CTCs from blood samples relied on interactions with known tumor-specific marker proteins, potentially missing cells that did not express those particular markers. The device used in the current study, … Continue reading →

Cellular therapeutics -- using intact cells to treat and cure disease -- is a hugely promising new approach in medicine but it is hindered by the inability of doctors and scientists to effectively track the movements, destination and persistence of these cells in patients without resorting to invasive procedures, like tissue sampling. In a paper published September 17 in the online journal Magnetic Resonance in Medicine, researchers at the University of California, San Diego School of Medicine, University of Pittsburgh and elsewhere describe the first human tests of using a perfluorocarbon (PFC) tracer in combination with non-invasive magnetic resonance imaging (MRI) to track therapeutic immune cells injected into patients with colorectal cancer. "Initially, we see this technique used for clinical trials that involve tests of new cell therapies," said first author Eric T. Ahrens, PhD, professor in the Department of Radiology at UC San Diego. "Clinical development of cell therapies can be accelerated by providing feedback regarding cell motility, optimal delivery routes, individual therapeutic doses and engraftment success." Currently, there is no accepted way to image cells in the human body that covers a broad range of cell types and diseases. Earlier techniques have used metal ion-based vascular MRI contrast … Continue reading →

9 Global Options Stem Cell Therapy for Parkinson's Disease Parkinson's disease is a neuromuscular condition that affects millions of people around the world. Uncontrollable movement of the body muscles along with strong shaking and trembling of extremiti... By: placidways … Continue reading →

Stem Cell Therapy Professional Football Player James Lee a Professional Football player is back in action thanks to stem cell therapy and Dr. Dennis M. Lox MD. Dr. Lox | http://www.drloxstemcells.com | (844) 440-8503. By: Dr. Lox … Continue reading →

Stem Cell Therapy | why no more news about embryonic stem cells http://www.arthritistreatmentcenter.com Is embryonic stem cell research passe? Next How come no more news about embryonic stem cells? Embryonic stem cells come from human embryos and these... By: Nathan Wei … Continue reading →

PUBLIC RELEASE DATE: 18-Sep-2014 Contact: Louise Walsh louise.walsh@admin.cam.ac.uk 44-012-237-65443 University of Cambridge @Cambridge_Uni Stem cells hold great promise as a means of repairing cells in conditions such as multiple sclerosis, stroke or injuries of the spinal cord because they have the ability to develop into almost any cell type. Now, new research shows that stem cell therapy can also work through a mechanism other than cell replacement. In a study published today in Molecular Cell, a team of researchers led by the University of Cambridge has shown that stem cells "communicate" with cells by transferring molecules via fluid filled bags called vesicles, helping other cells to modify the damaging immune response around them. Although scientists have speculated that stem cells might act rather like drugs in sensing signals, moving to specific areas of the body and executing complex reactions this is the first time that a molecular mechanism for this process has been demonstrated. By understanding this process better, researchers can identify ways of maximising the efficiency of stem-cell-based therapies. Dr Stefano Pluchino from the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, who led the study, said: "These tiny vesicles in stem cells contain molecules like proteins and nucleic … Continue reading →

ABC Ralph Bright harvests stem cells using the liposuction. Serious questions have been raised about a stem cell doctor working in Western Sydney who charges $9,000 per procedure and uses methods that are untested by clinical trials. An investigation by the ABC's 7.30 program has revealed that Dr Ralph Bright bought his liposuction-based technology from an American company. The US company is now the subject of a multi-million dollar fraud action, which has revealed the cells being marketed as live were in fact dead. Dr Bright, of Macquarie Stem Cells, is a former GP and self-taught cosmetic surgeon. He has been working with stem cells for four years, treating more than 400 patients, including the late model Charlotte Dawson, cricketer Geoff Lawson and Olympic volleyballer Kerri Pottharst. Dr Bright has licensed his methods to other practitioners around the country and because they use the patients' own cells he is not regulated by the Therapeutic Goods Administration (TGA). Stem cells are often hailed as a miracle cure, but the nation's top stem cell scientists are warning that buyers should beware of these sorts of procedures, which are yet to be subjected to clinical trials. Professor of Stem Cell Science at the … Continue reading →

ABC Ralph Bright harvests stem cells using the liposuction. Serious questions have been raised about a stem cell doctor working in Western Sydney who charges $9,000 per procedure and uses methods that are untested by clinical trials. An investigation by the ABC's 7.30 program has revealed that Dr Ralph Bright bought his liposuction-based technology from an American company. The US company is now the subject of a multi-million dollar fraud action, which has revealed the cells being marketed as live were in fact dead. Dr Bright, of Macquarie Stem Cells, is a former GP and self-taught cosmetic surgeon. He has been working with stem cells for four years, treating more than 400 patients, including the late model Charlotte Dawson, cricketer Geoff Lawson and Olympic volleyballer Kerri Pottharst. Dr Bright has licensed his methods to other practitioners around the country and because they use the patients' own cells he is not regulated by the Therapeutic Goods Administration (TGA). Stem cells are often hailed as a miracle cure, but the nation's top stem cell scientists are warning that buyers should beware of these sorts of procedures, which are yet to be subjected to clinical trials. Professor of Stem Cell Science at the … Continue reading →